Profil
Steven A. Lisi is the founder of Mico Innovations LLC.
Mr. Lisi is Chairman & Chief Executive Officer at Beyond Air Ltd. since 2017.
Mr. Lisi is Chairman at Beyond Cancer, Ltd. Mr. Lisi is Director at Ait Ltd. since 2016.
Mr. Lisi was Chairman & Chief Executive Officer at Beyond Air, Inc. from 2017 to 2026.
Mr. Lisi was Director at Convatec Accessories Ltd. Mr. Lisi was Director at Incysus Ltd. Mr. Lisi was Portfolio Manager at S.A.C.
Capital Advisors LP.
Mr. Lisi was Partner at Deerfield Management Co. LP.
Mr. Lisi was Senior VP-Business & Corporate Development at Flamel Technologies SA from 2012 to 2015.
Mr. Lisi was Principal at Mehta Partners LLC.
Mr. Lisi was Portfolio Manager at Millennium Management LLC from 2004 to 2005.
Mr. Lisi was Principal at Panacea Asset Management LLC.
Mr. Lisi was Senior VP-Business & Development at Avadel Pharmaceuticals Plc.
Mr. Lisi completed graduate studies at Pepperdine University.
Mr. Lisi completed undergraduate studies at State University of New York at Albany.
Aktive Positionen von Steven Lisi
| Unternehmen | Position | Beginn |
|---|---|---|
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Operates as a clinical-stage medical device and biopharmaceutical company | Vorstandsvorsitzender | 01.06.2017 |
Mico Innovations LLC | Gründer | - |
Ait Ltd.
Ait Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Direktor/Vorstandsmitglied | 01.06.2016 |
Beyond Cancer, Ltd.
Beyond Cancer, Ltd. BiotechnologyHealth Technology Operates as a development stage biopharmaceutical and medical device company that develops nitric oxide therapies | Vorsitzender | - |
Ehemalige bekannte Positionen von Steven Lisi
| Unternehmen | Position | Ende |
|---|---|---|
| BEYOND AIR, INC. | Vorstandsvorsitzender | 27.03.2026 |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | 07.04.2015 |
Panacea Asset Management LLC
Panacea Asset Management LLC Investment ManagersFinance Panacea invests long/short in stocks of various types of healthcare companies, including biotech, pharmaceuticals, healthcare services, HMOs, insurance and medical-technology companies. | Chief Investment Officer | 29.02.2008 |
Millennium Management LLC
Millennium Management LLC Financial ConglomeratesFinance Millennium Management employs a global multi-strategy investment approach, opportunistically engaging in a broad array of trading and investing strategies across a wide group of diversified managers. The firm prefers trading teams that produce small gains on winning days and smaller losses on losing days. They emphasize diversity in asset classes, industry sectors and geographic boundaries and invest in a variety of domestic and international equity and debt securities, currencies, futures, forwards, options and other instruments. | Portfolio Manager-Aktien | 22.08.2005 |
| AVADEL PHARMACEUTICALS PLC | Corporate Officer/Principal | - |
Ausbildung von Steven Lisi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Deerfield Management Co. LP
Deerfield Management Co. LP Investment ManagersFinance Deerfield conducts extensive fundamental research into healthcare sector assets and investment opportunities. The firm makes use of this fundamental research to identify investment opportunities, determine how best to structure or “express” an investment thesis, direct the purchase and sale of securities, negotiate structured investment transactions, and generally manage and invest the assets of the Funds. The majority of Fund investments are made in companies that are organized in the United States or that issue securities available in the US public securities markets. | Finance |
S.A.C. Capital Advisors LP
S.A.C. Capital Advisors LP Investment ManagersFinance S.A.C. Capital Advisors seeks to invest in the stocks of companies with short-term growth catalysts. The firm employs quantitative techniques and merger arbitrage strategies. | Finance |
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Mico Innovations LLC | |
Mehta Partners LLC
Mehta Partners LLC Investment ManagersFinance Provides investment research | Finance |
Millennium Management LLC
Millennium Management LLC Financial ConglomeratesFinance Millennium Management employs a global multi-strategy investment approach, opportunistically engaging in a broad array of trading and investing strategies across a wide group of diversified managers. The firm prefers trading teams that produce small gains on winning days and smaller losses on losing days. They emphasize diversity in asset classes, industry sectors and geographic boundaries and invest in a variety of domestic and international equity and debt securities, currencies, futures, forwards, options and other instruments. | Finance |
Pepperdine University
Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Albany
State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Panacea Asset Management LLC
Panacea Asset Management LLC Investment ManagersFinance Panacea invests long/short in stocks of various types of healthcare companies, including biotech, pharmaceuticals, healthcare services, HMOs, insurance and medical-technology companies. | Finance |
Convatec Accessories Ltd.
Convatec Accessories Ltd. Medical/Nursing ServicesHealth Services Provides healthcare and veterinary arenas | Health Services |
Beyond Air, Inc.
Beyond Air, Inc. Medical SpecialtiesHealth Technology Developing a platform of nitric oxide generators and delivery systems | Health Technology |
Beyond Air Ltd.
Beyond Air Ltd. BiotechnologyHealth Technology Operates as a clinical-stage medical device and biopharmaceutical company | Health Technology |
Avadel Pharmaceuticals Plc
Avadel Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Ait Ltd.
Ait Ltd. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Incysus Ltd.
Incysus Ltd. BiotechnologyHealth Technology Develops shelf cellular therapy for the treatment of solid tumor cancers | Health Technology |
Beyond Cancer, Ltd.
Beyond Cancer, Ltd. BiotechnologyHealth Technology Operates as a development stage biopharmaceutical and medical device company that develops nitric oxide therapies | Health Technology |
















